Patent Application
20190307950
The present invention relates generally to the field of flow restrictors, and more specifically to microflow restrictors useful in medical applications.
Microflow restrictors are commonly used in the medical field in conjunction with infusion pump systems to regulate the flow of medicine and other fluids to a patient. Microflow restrictors are typically able to regulate fluid flow in the range of less than 500 milliliters per hour, but can regulate higher rates of flow if necessary. Typical pressures under which infusion pump systems operate are less than about 60 kPa.
Considerable difficulties with existing microflow restrictors are recognized in the prior art. Specifically, with regard to maintaining flow through the restrictor over time, prior art microflow restrictors are believed to be highly susceptible to seizing due to the presence of microparticulates and bubbles in the fluid. The small amount of fluid flowing through the restrictor and the minimal operating pressures of infusion pumps is believed to provide insufficient pressure to move or otherwise overcome the particulates or break the bubbles and permit fluid to continue to flow through the restrictor. To address this issue, select prior art microflow restrictors have been specifically designed to create multiple tortuous paths for fluid, such paths designed to break bubbles and permit particulates to be circumvented by the fluid.
However, prior art flow restrictors are expensive to manufacture due to the very small fluid pathways utilized. Some existing flow restrictors are manufactured using costly processing and post-processing steps. In addition, existing flow restrictors suffer from decreasing flow rates over time due to micro leaks within the flow restrictors.
The inventors have discovered, unexpectedly in view of the prior art, that triboelectric charges created by the fluid flowing through the microflow restrictor impact the flow of fluid through the restrictor over time. By managing the triboelectric effects of the fluid and microflow restrictor, the microflow restrictor is able to consistently function as intended over time. Additionally, the unique configuration of the fluid pathway in the present invention permits better management of triboelectric effects while at the same time simplifying manufacturing processes and reducing manufacturing costs. Hence, the present invention enables management of very small amounts of fluid flow over time without significant interference from triboelectric effects in a microflow restrictor configuration that permits manufacturing in a more cost-effective manner.
The present invention is directed to a medical fluid microflow assembly which includes an assembly fluid inlet and an assembly fluid outlet. A mandrel having an exterior surface is positioned within a cavity of a housing so that at least a portion of the exterior surface of the mandrel is substantially parallel to at least a portion of an interior surface of the cavity. At least one protrusion extends from either the interior surface of the cavity or the exterior surface of the mandrel, each protrusion abutting either the exterior surface of the mandrel or the interior surface of the cavity to form a sealed fluid channel. The sealed fluid channel may include a channel inlet positioned proximate to the assembly fluid inlet and a channel outlet positioned proximate to the assembly fluid outlet.
The sealed fluid channel has a length and an average width and, in certain embodiments, the length of the channel may be greater than ten times the average width of the sealed fluid channel. The average width of the sealed fluid channel may be at least 50 microns and in some embodiments maybe wider than 50 microns. The sealed fluid channel may have a constant width along at least a portion of the length of the sealed fluid channel, or may have a width that varies along at least a portion of the length of the channel. In certain embodiments, the width of the sealed fluid channel may increase along at least a portion of the length of the channel so that the sealed fluid channel is widest proximate to the channel outlet.
The exterior surface of the mandrel may be variously shaped and may have a conical shape so that the sealed fluid channel may extend about the exterior surface of the mandrel in a helical pattern.
In particular embodiments, a portion of the exterior surface of the mandrel may be planar. At least a portion of the interior surface of cavity may be configured to be substantially parallel to the planar portion of the exterior surface of the mandrel. In configurations where at least two portions of the exterior surface of the mandrel are planar, both portions being substantially parallel to at least a portion of the interior surface of the cavity, a protrusion may be positioned on each planar surface of either the mandrel or the cavity so that at least two sealed fluid channels are formed.
The protrusion may extend from either the planar portion of the exterior surface of the mandrel or the interior surface of the cavity. In some embodiments, protrusions may extend from the exterior surface of the mandrel and the interior surface of the cavity.
The sealed fluid channel has an average height which is the average distance between the exterior surface of the mandrel and the interior surface of the cavity of the housing in some embodiments. The sealed fluid channel also has an average width, and in some embodiments the average width of the sealed fluid channel is at least the same as, e.g., at least 3 times, at least 5 times, or at least 10 times, the average height of the sealed fluid channel. In certain configurations, the average height of the sealed fluid channel may be equal to or greater than about five (5) microns and less than about five hundred (500) microns. At least one of the surfaces which form the sealed fluid channel may have an average surface roughness that is less than about ten percent (10%), e.g., less than about five percent (5%), of the average height of the sealed fluid channel, and ideally, as smooth as possible.
The protrusion may include a first surface and a second surface, the first and second surfaces forming an apex which contacts either the exterior surface of the mandrel or the interior surface of the cavity to form the sealed fluid channel. In some configurations the apex may be formed as a radius, which may in certain configurations be greater than or equal to 0.001 microns.
The sealed fluid channel may be at least partially formed from a material that exhibits a substantially neutral triboelectric charge when in contact with a saline or glucose solution. To achieve this, the sealed fluid channel may be at least partially formed from polycarbonate. Portions of the sealed fluid channel may also be formed from polysulfone, acrylic, PVC, Nylon, Polyethylene, Polypropylene polymers, or combinations of these materials with polycarbonate.
The medical fluid microflow assembly may be configured so that the sealed fluid channel permits fluid to flow through the assembly fluid outlet at a flow rate greater than about 0.01 ml per hour, and in some configurations at a flow rate of less than about 500 ml per hour.
In accordance with another aspect of the present invention, a method for manufacturing a medical fluid microflow assembly is provided. The method may include forming a medical fluid microflow assembly housing comprising a cavity, and forming a mandrel comprising an exterior surface. In addition, prior to hardening at least one of the material of the medical fluid microflow assembly housing or the mandrel, the mandrel may be positioned within the cavity of the medical fluid microflow assembly housing such that at least one partially-hardened protrusion extending from either an interior surface of the cavity or the exterior surface of the mandrel abuts either the exterior surface of the mandrel or the interior surface of the cavity to form a sealed fluid channel. The partially-hardened material has a greater capacity to deform and thereby compensate for geometric and manufacturing variations, forming a more perfect seal between microflow assembly housing and mandrel, and decreasing propensity for microleaks. After positioning the mandrel within the cavity of the medical fluid microflow assembly housing, the mandrel and/or the medical fluid microflow assembly housing are hardened either through time, temperature, chemical, or other means. In one embodiment, the medical fluid microflow assembly is assembled when all components are fully hardened except for the medical fluid microflow assembly housing which is partially-hardened during assembly. In another embodiment, only the mandrel is partially hardened during assembly of the medical fluid microflow assembly.
In another embodiment, the method includes achieving a desired flow rate through the microflow assembly. For example, the method may include loading a medical fluid microflow assembly housing having a cavity into a fixture, and applying a curing adhesive on a portion of the interior surface of the cavity of the housing between the interior surface of the cavity and the post. The method further may include monitoring an airflow rate of a pressurized gas or a pressure differential between the inlet and outlet, e.g. a vacuum at the outlet, passing the pressurized gas through the sealed fluid channel from the channel inlet to the channel outlet, and adjusting the pressing of the post against the mandrel based on the monitored airflow rate. The curing adhesive may then be cured when the measured airflow rate reaches a target airflow rate.
The invention will now be described with reference to one or more embodiments which are illustrated in the drawings. It is to be understood that the detailed description is provided by way of explanation of the invention and is not meant as a limitation of the invention. For instance, features illustrated and described as part of one embodiment may be used on another embodiment to yield a still further embodiment. It is intended that the present invention include these and other modifications and variations to the embodiments described herein.
As shown in
Microflow assembly 10 may be configured to engage and retain various articles at its assembly fluid inlet 28 and assembly fluid outlet 26 (both shown in
Microflow restrictor assembly 10 may be utilized to restrict the flow of fluids to the patient. Microflow restrictor assembly 10 may be connected to reservoir 112 via medical tubing 114 and may be connected to a patient using a variety of mechanisms. For example and as shown in
Referring to
As seen in
Post 14 is configured to move dowel 18 and mandrel 20 into cavity 80 within housing 22. In select embodiments, post 14 and dowel 18 may be formed as a single element. Depending on the suitability for specific manufacturing processes, post 14, seal 16, dowel 18, and connector 12 may be formed as one or multiple elements. For example, post 14 and dowel 18 may be formed as a single element. In other embodiments, post 14, dowel 18, and connector 12 may be formed as a single element. Post 14, mandrel 20, and dowel 18 may be formed as a single element or may be joined via adhesive, ultrasonic welding, screws or snap-together features.
Seal 16 may be formed as a part of post 14 or may be separately formed and positioned between post 14 and interior surface 86 of housing 22. For example, seal 16 may be positioned within detent 46 of post 14 such that seal 16 is in contact with an exterior surface of post 14 and interior surface 86 of housing 22. Seal 16 functions to ensure that fluid is transmitted only through passage 42 and prevents fluid bypassing the restricted flow channel which meters the appropriate flow of fluid through microflow assembly 10. Seal 16 also helps prevent adhesive used to join post 14 to interior surface 86 of housing 22 from interfering with the flow of fluid through microflow restrictor assembly 10. Seal 16 may be formed from any of a variety of materials including silicone, rubber or other suitable materials. In certain embodiments, post 14 and seal 16 may be formed as a single element, and seal 16 may be co-molded with post 14, mandrel 20, dowel 18, or housing 22. Post 14, seal 16, and connector 12 may also be formed as a single element.
As shown in
Connector 12 includes opening 34 which may extend through connector 12. Threads 36 may be formed into interior surface 35 of opening 34, to permit a source of fluid to be releasably engaged to microflow assembly 10. Luer lock fittings and snap-fit connections are particularly well-suited for use in conjunction with connector 12.
As shown in
End 78 of housing 22, which is adjacent to outlet portion 74, abuts recessed surface 38 of connector 12. Shoulder 40 of connector 12 may extend around at least a portion of outlet portion 74 of housing 22. In certain embodiments, housing 22 and connector 12 may be press-fit together or may be secured by adhesive or other joining processes such as ultrasonic welding, retention features, or fasteners. As depicted in the microflow assembly of
The embodiment of the microflow assembly depicted in
As shown in
As shown in
As shown in
As best shown in
Post 14, shown in
The gap between post 14 and housing 22 may range from about 0.01 mm to about 1.25 mm, and may be about 0.075 mm in selected embodiments.
As seen in
Referring to
In particular embodiments, protrusion 90 has a length that extends in a substantially continuous helix on at least a portion of interior surface 86 or exterior surface 66. Protrusion 90 may be positioned on such surface in different manners. For example, the distance between the successive wraps of protrusion 90, or pitch of protrusion 90, may increase or decrease with respect to the direction of flow of fluid through the assembly. The pitch of protrusion 90 may also be uniform or non-uniform along the length of the surface. For example and as illustrated in
Many configurations of protrusion 90 are suitable for use in the present invention, including protrusions having cross-sectional shapes which are triangular, elliptical, orthogonal, or circular. However, it is desirable to select a cross-sectional area at apex 96 (shown in
The local deformation of protrusion 90 is preferably configured to avoid the creation of hoop stresses in housing 22 sufficient to cause cracking. The materials selected for protrusion 90, housing 22, and mandrel 20 will impact the robustness of microflow assembly 10 to cracking. Additionally, the angle of exterior surface 66 of mandrel 20 will impact the resistance of housing 22 to cracking. In some embodiments, an angle of seven degrees (fourteen degree included angle) permits mandrel 20 to be self-locking while not producing excessive hoop stresses. Angles of between five and nine degrees (ten and eighteen degree included angles) are also suitable for use in the present invention.
As described above, sealed fluid pathway 100 of the present invention is formed by interior surface 86 of housing 22 and exterior surface 66 of mandrel 20. The particular configuration of mandrel 20 and housing 22 may be variously structured to achieve sealed fluid pathway 100. In some embodiments, interior surface 86 of housing 22 provides a tapered conical recess into which mandrel 20 is positioned. Exterior surface 66 of mandrel 20 may be formed as a corresponding tapered conical surface from which protrusions 90 extend.
As shown in
As shown in
Sealed fluid channel 100 may encircle mandrel 20 or be positioned on a single side of mandrel 20.
Protrusion 90 may be configured specifically for the particular surface upon which it is positioned. For example, protrusion 90 which, as shown in
It is desirable that the height of protrusions 90 are preferably uniform.
In some embodiments, the angles of interior surface 86 of housing 22 and exterior surface 66 of mandrel 20 should be selected so that their uppermost portions present a similarly tapered conical form which enabled mandrel 20 and housing 22 to become self-locking. To achieve this, the taper angle should be essentially at or slightly below the self-clinching angle for the particular material that is being utilized to form protrusions 90 on mandrel 20 and housing 22. For example, polycarbonate materials have a self-clinching angle that is approximately 15 degrees (a 30 degree included angle). Utilizing such a self-locking feature permits a wider range of bonding processes to be successfully utilized on microflow assembly 10.
Referring to
The configuration of sealed fluid channel 100 may encourage laminar flow, which may be helpful in maintaining an air/water correlation of flow. Fluid flows through sealed fluid channel 100, exiting proximate to dowel 18. Seal 16 prevents the fluid from exiting housing 22 except through passage 42, which ends at assembly outlet 26. Different configurations of microflow restrictor 10 may also include alternate configurations of post 14, connector 12, and housing 22.
Sealed fluid channel 100 may, in particular embodiments, have a height that is greater than about five (5) microns and less than about five hundred (500) microns and a width that is greater than about fifty (50) microns and less than about six thousand (6000) microns. The height of sealed fluid channel 100 may be adjusted by the distance mandrel 20 is inserted into housing 22. The fluid flow through sealed fluid channel 100 may be selected by manufacturing sealed fluid channel 100 with a specific height H, a specific width W, and a specific length L.
Referring to
Microflow restrictor assembly 10′ may include fill inlet 1502 having a fluid channel extending therethrough from fill inlet 1502 to one-way valve 1504 disposed within reservoir 112′. Reservoir 112′ may receive fluid via fill inlet 1502, and one-way valve 1504 may prevent fluid from exiting reservoir 112′ through fill inlet 1502. One-way valve 1504 may be any one-way valve known in the art. Microflow restrictor assembly 10′ may include inlet 1508 which may permit fluid from reservoir 112′ to flow through microflow restrictor assembly 10′ and ultimately through medical tubing 116′. In addition, reservoir 112′ may be secured on microflow restrictor assembly 10′ via ring clamp 1506.
Certain embodiments of microflow restrictor 10 may be assembled in equipment configured to flow air through microflow restrictor 10 from assembly inlet 28 to assembly outlet 26 while a load, either static or impulse, is applied to post 14 which moves mandrel 20 into the appropriate position in housing 22.
Pressure applied to post 14 is used to adjust the rate of fluid flow through microflow assembly 10. Flow rates between 500 ml/hour and 0.5 ml/hour are attainable, and in certain embodiments flow rates between 0.5 ml/hour and 0.01 ml/hour may be attained. As pressure is applied to post 14, the outlet end of post 14 presses on surfaces 60 of bosses 58 which are positioned on dowel 18. Lower surface 54 of dowel 18 moves mandrel 20 further into cavity 80. In selected embodiments, protrusion 90 may be compressed or deformed to reduce the height H of sealed fluid channel 100.
Adjustment of the flow rate and sealing of sealed fluid channel 100 depend on the deformation of protrusion 90 and the surface against which it is deformed. The configuration of apex 96 of protrusion 90 may vary widely, however the smaller area of apex 96 will permit local stresses to form at apex 96 which may exceed the plastic limit of the material from which the protrusion is formed.
To enable the deformation of protrusion 90 positioned on interior surface 86 of housing 22, the material selected to form protrusion 90 may be softer than the material used to form mandrel 20. In contrast, the material used to form mandrel 20 may be selected so that it is softer than the material used to form protrusion 90. In this situation, mandrel 20 will deform around protrusion 90. The same material may be used to form both protrusion 90 and mandrel 20, permitting both to be deformed to form an air-tight seal.
As air flows through microflow assembly 10, the air flow is measured and, in many embodiments of the present invention, the configuration of sealed fluid channel 100 provides for an air/water correlation which will permit accurate calibration of the device. Any potential leaks through seal 16 or other portions of the device will occur after the fluid has passed through sealed fluid channel 100, enabling an accurate flow measurement to be achieved.
An adhesive such as a UV curing adhesive may be applied between post 14 and housing 22 prior to insertion into housing 22 and application of the load to post 14. The desired flow rate through microflow assembly 10 is achieved before the adhesive is cured. The adhesive may also be applied after mandrel 20 has been inserted to the correct position within housing 22 and the desired flow rate achieved, although bumping or other handling may alter the position of post 14 or mandrel 22 and hence the flow rate. Once the adhesive cures, the dimensions of sealed fluid channel 100 are fixed.
Injection molding is an economical and accurate method by which portions of microflow restrictor 10 may be manufactured. During the injection molding process, an injection mold will wear and protrusion 90 may increase in height due to this change. However, the method of assembly accommodates this potential change in the manufacturing process and enables microflow restrictor 10 to be assembled to a pre-set flow rate in the same manner. The method of assembly also accommodates variations in the manufacture of the components.
Referring now to
Similarly, at steps 1604, 1606, and 1608, mandrel 20 having exterior surface 66, post 14 having assembly fluid outlet 26, and connector 12 having opening 34 extending therethrough, are formed from a material, e.g., plastic, using a machine, e.g., injection molding machine. At step 1610, mandrel 20 is positioned within cavity 80 of housing 22 such that at least one partially-hardened uncured protrusion 90 extending from either interior surface 86 of cavity 80 or exterior surface 66 of mandrel 20, as described above, abuts either exterior surface 66 of mandrel 20 or interior surface 86 of cavity 80 to form a sealed fluid channel. The sealed fluid channel includes a channel inlet positioned proximate to fluid inlet 28 and a channel outlet positioned proximate to fluid outlet 26, thereby reducing decrease of flow rate over time within the medical fluid microflow assembly.
The inventors determined, unexpectedly, that using partially-hardened uncured plastic to form protrusion 90 improved consistency in flow rate over time and prevented or minimized the decrease in flow rate over time (“sagging”) which may result from micro leaks between the protrusions and the smooth surface of either exterior surface 66 of mandrel 20 or interior surface 86 of housing 22.
The inventors discovered that the slightly lower hardness allows the spiral feature, e.g., protrusion 90, to deform more, and to the point, enough to form an impermeable seal. In one embodiment, protrusion 90 on interior surface 86 of housing 22 is “green,” whereas exterior surface 66 of mandrel 20 is hardened plastic. In another embodiment, exterior surface 66 of mandrel 20 is “green,” whereas protrusion 90 on interior surface 86 of housing 22 is hardened plastic. In yet another embodiment, both protrusion 90 on exterior surface 66 of mandrel 20 and interior surface 86 of housing 22 are “green”. In contrast to the industry standard to wait until plastic cures before assembly, the inventors discovered that assembling components of a medical fluid microflow assembly prior to hardening reduces rate of change of flow rate. For example, the partially-hardened components assembled together may cure to fill in undesirable microgaps between components resulting from the manufacturing process.
Sealing between housing 22 and mandrel 20 is critical to providing consistent flow rates due to the sagging phenomenon described above. Other methods to seal may include, e.g., laser, photon, solvent, vibration, ultrasonic, etc.
At step 1612, post 14 is pressed against mandrel 20 within cavity 80 of housing 22 such that assembly fluid outlet 26 of post 14 is in fluid communication with the channel outlet. At step 1614, connector 12 is secured to housing 22 such that at least a portion of post 14 is positioned within opening 34 of connector 12. As described above, connector 12 may be designed so that connector 12 snaps onto, or is otherwise mechanically connected to, post 14.
In conventional practice, most plastic parts are made in large batches at external vendors and warehoused before assembly, thus providing adequate time for the plastic to harden. However, in accordance with an aspect of the present invention, the uncured components are assembled in a relatively quick time (e.g., less than 12 hours after forming each component, less than 8 hours after forming each component, less than 6 hours after forming each component), thereby reducing sagging. At step 1616, housing 22, mandrel 20, post 14, and connector 12 are hardened/cured. Cure time may be a function of the particular plastic. For example, the cure time/time to harden of PolyCarbonate is 3-5 days, e.g., 36-60 hours.
While steps 1610-1616 describe assembling multiple partially hardened components to form the microflow restrictor assembly, it should be understood that not all components need be partially hardened. For example, in one embodiment, the microflow restrictor assembly is assembled when all components are fully hardened except for housing 22 which is partially-hardened during assembly. In another embodiment, only the mandrel is partially hardened during assembly of the medical fluid microflow assembly. After assembly, housing 22 is allowed to harden/cure, thereby reducing sagging.
Referring now to
At step 1704, a curing adhesive, e.g., UV cure epoxy, is applied on interior surface 86 of housing 22. The adhesive may be applied to a portion of interior surface 86 of housing 22 in the cavity between interior surface 86 and post 14. The adhesive, e.g., Dymax 1160-m-sv01, may include a fluorescing element such that visual or machine vision inspection is easier. In one embodiment, the adhesive may be applied to interior surface 86 of housing 22 before housing 22 is loaded into the fixture. In yet another embodiment, the adhesive may be applied to interior surface 86 of housing 22 after the components of microflow restrictor assembly 10 are cured and microflow restrictor assembly 10 is fixed.
At step 1706, mandrel 20 is positioned within cavity 80 of housing 22 such that at least one partially-hardened protrusion 90 extending from either interior surface 86 of cavity 80 or exterior surface 66 of mandrel 20 abuts either exterior surface 66 of mandrel 20 or interior surface 86 of cavity 80 to form a sealed fluid channel as described above.
At step 1708, post 14 is pressed against mandrel 20 within cavity 80 of housing 22 to compress microflow restrictor assembly 10 by, e.g., the motorized linear actuator or any mechanism well known in the art that may slowly, but consistently increase compression force such as hydraulic or rotary actuators. As described above, using partially-hardened plastic, protrusion 90 may deform more, producing a good seal and preventing sagging.
At step 1710, the airflow rate of pressurized gas, e.g., air or N2, is monitored via the flow meter prior to being passed through the sealed fluid channel at step 1712. In one embodiment, differential pressure across the sealed fluid channel may be monitored via the flow meter. The flow meter provides a near instantaneous value of the air flow rate through the sealed fluid channel. Since the airflow rate correlates with the fluid flow rate, microflow restrictor assembly 10 may be tuned to a desired fluid flow rate by adjusting the compression of microflow restrictor assembly 10 at step 1714 until the airflow rate monitored at step 1708 reaches a target airflow rate.
When the target airflow rate is achieved, and accordingly the desired fluid flow rate through microflow restrictor assembly 10, at step 1716, the adhesive is cured, e.g., by activating the UV light, which cures the adhesive and fixes the location of post 14, and accordingly, the location of mandrel 20 within housing 22. As will be understood by one skilled in the art, the adhesive may be cured by any curing means well known in the art.
Referring now to
As shown in
The inventors have discovered, unexpectedly in view of the prior art, that the seizing phenomenon is not due to bubbles and microparticulates, but rather to triboelectric charges created by the fluid flowing through the microflow restrictor. Specifically, the inventors noted that the flow of saline through a restrictor was uninterrupted despite the increased potential for microparticulate clogging while medical grade water for injection exhibited a consistently slower rate of flow over time.
Triboelectric charging is a type of contact electrification in which certain materials come into contact with each other and exchange electrons. This effect is amplified as the fluid and the material of the microflow restrictor assembly are in sliding contact. This causes the materials to become electrically charged. The polarity and strength of the charges that are produced will differ, based on the specific materials and surface roughness of those materials, and the distance between the surfaces. By managing the triboelectric effects of the combined fluid and microflow restrictor, the microflow restrictor is able to consistently function as intended over time.
Managing the triboelectric charge created by a fluid flowing through sealed fluid pathway 100 will necessitate careful consideration of the optimal materials from which mandrel 20 and housing 22 are formed, as well as configuring the surface roughness of each of the surfaces which form sealed fluid channel 100. The materials may be selected to match specific medical fluids. For example, polycarbonate material may be selected for medical saline or glucose solution, including additional medications.
The surface roughness used herein is the average surface roughness Ra which characterizes the surface based on the absolute value of the vertical deviations of the roughness profile from the mean line and is calculated as follows, where y is the height of the deviation from the mean line:
In certain embodiments that are selected for particular applications, interior surface 86 and exterior surface 66 preferably have a surface roughness of between about 0.012 microns and about 5 microns. The surface roughness is desirably less than ten percent (10%), e.g., less than five percent (5%), of the height H of sealed fluid channel 100. While not every surface which forms sealed fluid channel 100 will contact fluid, it is preferred in some embodiments that all surfaces which form sealed fluid channel 100 have a surface roughness which significantly reduces any triboelectric effect from the fluid flowing across the surface. The roughness of surfaces 66 and 86 may also differ from one another.
While many materials may be used to form microflow restrictor assembly 10, including metals and glass, polymers are generally an economical and adaptable material for use. A wide range of polymers is suitable for use in the present invention, and should be selected to correspond to the particular use of the microflow assembly. Polymers such as polycarbonate, polysulfones and acrylic plastics such as poly(methyl methacrylate) (PMMA), PVC (Poly Vinyl Chloride), Nylon, Polyethylene, and polypropylene are useful as materials for forming portions of the microflow restrictor assembly. In particular, medical grade polycarbonate may be used for many potential applications of the microflow assembly. In some embodiments, the polymer selected may be matched to a particular fluid to reduce the triboelectric effects for a particular application of the microflow restrictor assembly. In some embodiments, the material chosen should exhibit a minimal amount of creep.
It should be appreciated by those skilled in the art that various modifications and variations may be made to features of the medical fluid microflow restrictor described herein without departing from the scope and spirit of the invention. It is intended that the invention include all such variations.
This application is a divisional of U.S. patent application Ser. No. 15/438,270, filed Feb. 21, 2017, which claims the benefit of priority of U.S. Provisional Patent Application Ser. No. 62/298,168, filed Feb. 22, 2016, the entire contents of each of which are incorporated herein by reference.
| Number | Date | Country | |
|---|---|---|---|
| 62298168 | Feb 2016 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 15438270 | Feb 2017 | US |
| Child | 16452382 | US |
